Display screen with a graphical user interface
Latest Eli Lilly and Company Patents:
- URI agonist/vasodilator
- Medication delivery device with needle carrier
- ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES AND ANTI-VEGFR-2 ANTIBODIES
- Dose regimens for use of LY3154207 in the treatment of dopaminergic CNS disorders
- Antibodies that bind human and mouse INSL5 and encoding nucleic acids thereof
Description
The sole FIGURE is a front view of a display screen with a graphical user interface showing the new design.
The broken lines of uneven length show the display screen and form no part of the claimed design.
Claims
The ornamental design for the display screen with a graphical user interface, as shown and described.
Referenced Cited
Patent History
Patent number: D983228
Type: Grant
Filed: Apr 21, 2021
Date of Patent: Apr 11, 2023
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Alec Michael Cerminaro (Chicago, IL), James Joseph Costigan, V (Chicago, IL), Faith Ilene Kaufman (Brooklyn, NY), Monika Paulaviciute (Brooklyn, NY)
Primary Examiner: Nicole C Shiflet
Application Number: 29/779,804
Type: Grant
Filed: Apr 21, 2021
Date of Patent: Apr 11, 2023
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Alec Michael Cerminaro (Chicago, IL), James Joseph Costigan, V (Chicago, IL), Faith Ilene Kaufman (Brooklyn, NY), Monika Paulaviciute (Brooklyn, NY)
Primary Examiner: Nicole C Shiflet
Application Number: 29/779,804
Classifications
Current U.S. Class:
Simulative (D14/492)
